Publications

Epclin, Oncotypedx and Prosigna in Lobular Breast Cancer (Ilc): Is There an Association with Ki67?

AuthID
P-00X-KXG

Author(s)

Leao, IIL

Zamora, E

Cayuela, R

Javierre, GV

Pimentel, I

Lapena, MC

Sanz, L

Puy, MB

De la Torre, J

Espinosa Bravo, M

Gorria, T

Oliveira, M

Manich, CS

Peg, V

Losada, MJV

Ezquerra, MB

Document Type

Abstract

Year published

2022

Published

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 33, Issue: 7, Pages: S614-S614 (1)

Conference

Annual Meeting of the European-Society-For-Medical-Oncology (Esmo), Date: SEP 09-13, 2022, Location: ELECTR NETWORK, Sponsors: European Soc Med Oncol

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.annonc.2022.07.200

Wos: WOS:000866211600161

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Epclin, Oncotypedx and Prosigna in Lobular Breast Cancer (Ilc): Is There an Association with Ki67?

Useful Links

Get Help

Federated Authentication (Click on the image)

Epclin, Oncotypedx and Prosigna in Lobular Breast Cancer (Ilc): Is There an Association with Ki67?

Useful Links

Get Help